Why Wedbush Sees Albireo More Than Doubling
Albiero Pharma, Inc. (NASDAQ: ALBO) recently received some positive news from the U.S. Food and Drug Administration (FDA) and it could have huge implications for the stock. One analyst actually sees the stock more…

















